Atlas Trials

Comparing the Efficacy of LDA, LHAA, and LA Regimens in Young Adults With Intermediate- and High-Risk Acute Myeloid Leukemia Eligible for Intensive Chemotherapy

Clinical trial NCT07651163 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07651163
Sponsor
First Affiliated Hospital of Zhejiang University
Status
ENROLLING_BY_INVITATION
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Acute Myeloid Leukemia (AML)Lisaftoclax
Start date
2026-03-01
Primary completion
2029-12-01
Enrollment
450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.